TCTMD vs BifurcAID 3D
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
TCTMD
Access cardiovascular news, journal summaries, conference coverage, and case studies. View slide presentations and videos in a mobile-friendly format.
- Daily news articles
- Journal summaries
- Conference coverage
- Case study library
- Slide presentation library
- Video library
Read full descriptionHide full description
The TCTMD app provides TCTMD subscribers with mobile access to content found on the TCTMD web site. Content includes: - Daily news articles, including journal summaries as well as cardiovascular conference coverage. - The case study, slide presentation, & video libraries are also available in a mobile friendly format with easily viewed reports, slides & videos respectively.
BifurcAID 3D
This app simplifies understanding bifurcation lesion treatment using 3D animations. It provides detailed instructions for various two-stent, provisional, and bailout techniques for left main and non-left main lesions.
- 3D animations for lesion treatment
- Detailed instructions
- Two-stent techniques
- Provisional techniques
- Bailout techniques
- Left main and non-left main lesions
Read full descriptionHide full description
BifurcAID 3D builds from the algorithm of BifurcAID and makes bifurcation lesion treatment even more easy to understand through 3D animations. Follow along with the detailed instructions for dedicated two-stent, provisional, and bailout techniques for left main and non-left main lesions.
Screenshots
Verdict
The clearest difference is rating: BifurcAID 3D at 5.0 against TCTMD's 4.0. BifurcAID 3D also leads on review sentiment (100% vs 86%) and ratings volume (4 vs 1). TCTMD's advantage is ads (none vs shown) and update cadence (every 3 months vs every 12 months). On price, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
BifurcAID 3D holds the better App Store score, 5.0 against 4.0. Both are backed by a comparable volume of ratings — 1 and 4 respectively. Written reviews point the same way: 86% of TCTMD's written reviews are positive against 100% of BifurcAID 3D's.
TCTMD ships an update every 3 months, BifurcAID 3D every 12 months. The most recent releases landed on October 30, 2026 and October 11, 2026 respectively.
| Parameter | TCTMD | BifurcAID 3D |
|---|---|---|
| Price | Free | Free |
| Rating | 4.0 (1 ratings) | 5.0 (4 ratings) — better |
| Positive reviews | 85.7% of reviews | 100.0% of reviews — better |
| Number of ratings | 1 | 4 — better |
| Update frequency | Every 3 months — better | Every 12 months |
| Ads | No — better | Yes |
| In-app purchases | No | No |
| Monetization | Free — better | Ad-supported |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 15.1 | 13.0 — better |
| Further details — not scored | ||
| Size | 30 MB | 204 MB |
| Age rating | 12+ | 17+ |
| Developer | Cardiovascular Research Foundation | Icahn School of Medicine at Mount Sinai |
Customer experience
TCTMD
BifurcAID 3D
In-app purchases
TCTMD
No in-app purchases
BifurcAID 3D
No in-app purchases
